FMP

FMP

Enter

SRDX - Surmodics, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/SRDX.png

Surmodics, Inc.

SRDX

NASDAQ

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

38.4 USD

-0.09 (-0.234%)

About

ceo

Mr. Gary R. Maharaj

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other market...

CIK

0000924717

ISIN

US8688731004

CUSIP

868873100

Address

9924 West 74th Street

Phone

952 500 7000

Country

US

Employee

376

IPO Date

Mar 4, 1998

SRDX Financial Summary

CIK

0000924717

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

868873100

ISIN

US8688731004

Country

US

Price

38.4

Beta

1.2

Volume Avg.

290.68k

Market Cap

547.85M

Shares

-

52-Week

25.17-42.44

DCF

2.88

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-426.67

P/B

-

Website

https://www.surmodics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SRDX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep